OFDT's working organisation

 

The French Monitoring Centre for Drugs and Drug Addiction (OFDT) relies on 2 Scientific Units (DATA and FOCUS), a General Secretariat, a communication and an accountancy department. The tasks of the Centre are carried out by a team of experts and researchers from different disciplines (statistics, demographics, epidemiology, economics, medicine, pharmacology, sociology) as well as administrative and technical staff.

This organisation aims to strengthen our capacity for studies, to develop synergies and partnerships while ensuring promotion and dissemination of our work.

 

Organisational chart (October 2021)

 

 


Directorate

 
 

Julien Morel d'Arleux
Director

vJMdA100x100px.jpg

 

Ivana Obradovic
Deputy director

vIO100x100px.jpg

 

 


Communication

Julie-Emilie Adès
Communication officer


 

 


"Data" Unit

Stanislas Spilka
Head of unit

vSS100x100px.jpg

 


Léo Bouthier
Scientific analyst

Leo_100x100.jpg

 

Alex Brissot
Scientific analyst

vAB100x100px.jpg

 

Vincent Eroukmanoff
Scientific analyst

VincentE100x100.jpg

 

Michel Gandilhon
Scientific analyst

vMG100x100px.jpg

 

Eric Janssen
Scientific analyst

vEJ100x100px.jpg

 

Olivier Le Nézet
Scientific analyst

vOL100x100px.jpg

 

Magali Martinez
Scientific analyst

vMM100x100px.jpg


Anna Ndiaye Delepoulle
Scientific analyst

 Anna100x100.jpg

 

Antoine Philippon
Scientific analyst

vAP100x100px.jpg

 

 


"Focus" Unit

Fabrice Guilbaud
Head of unit

homme-100x100.jpg

 


Agnès Cadet-Taïrou
Scientific analyst

vACT100x100px.jpg

 

Victor Detrez
Scientific analyst

Victor-Detrez-100x100.jpg

 

Marc-Antoine Douchet
Scientific analyst

Marc-Antoine-Douchet-100x100.jpg

 

Laura Duprat
Scientific analyst

Laura100_x100.jpg

 

Clément Gérome
Scientific analyst

vCG100x100px.jpg

 

Maitena Milhet
Scientific analyst

vMMb100x100px.jpg

 

Carine Mutatayi
Scientific analyst

vCM100x100px.jpg

 

Paul Neybourger
Scientific analyst

vpn100x100.jpg

 

Caroline Protais
Scientific analyst

vCPr100x100px.jpg

 

Clément Picot-Ngo
Scientific analyst

ClementP100x100.jpg

 

 


General Secretariat

Virginie Martin
Head of unit

vVM100x100px.jpg

 


Margaux Blanchon
Legal officer

vMB100x100px.jpg

 

Mickael da Silva
Assistant

Michael-Da-Silva-100x100.jpg

 

Thierry Delprat
Webmaster

vTD100x100px.jpg

 

Cristina Díaz-Gómez
Scientific analyst

vCDG100x100px.jpg

 

Anne de l'Eprevier
Liaison officer with EMCDDA

vAdE100x100px.jpg

 

Isabelle Michot
Information officer

vIM100x100px.jpg

 

Frédérique Million
Graphic designer

vFM100x100px.jpg

 

 


Financial resources

Pierre-Piquemal-Lagorre
Accountant

ppiquemal100x100.jpg

 

Laurence Grandjean
Deputy accountant

vLG100x100px.jpg

 

Mickael Da Silva
Accounting assistant

Michael-Da-Silva-100x100.jpg

 

Drugs in Europe


2021 EMCDDA European Drug Report

COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?

These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.

  Statistical Bulletin 2021

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.